Loading clinical trials...
Loading clinical trials...
To evaluate the best timing of the concomitant chemoradiotherapy among patients with NSCLC stage III not resectable treated by concomitant chemo-radiotherapy, either preceded by a induction chemothera...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Collaborators
NCT03620669 · NSCLC Stage IV, NSCLC Stage IIIB
NCT04027647 · NSCLC Stage IIIB, NSCLC Stage IIIC, and more
NCT05816499 · NSCLC Stage IV, NSCLC Stage IIIB, and more
NCT04147351 · NSCLC Stage IIIB~IV
NCT07150598 · NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC Stage IIIB~IV, and more
CHU Saint-Etienne Pneumologie
Saint-Etienne
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions